Article
Antiviral‐resistant hepatitis B virus: can we prevent this monster from growing?
22 Oct 2007
Abstract excerpt
Despite the recent progress in antiviral therapy of chronic hepatitis B, clinical experience has shown that antiviral drug resistance is inevitable with the administration of nucleoside analog monotherapy. The long-term persistence of the viral genome in infected cells and the high rate of spontaneous mutation is the basis for the selection of HBV mutants that are resistant to polymerase inhibitors. Selection of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
